Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

The Jupiter trial: key findings, controversies, and implications.

Nissen SE.

Curr Cardiol Rep. 2009 Mar;11(2):81-2. No abstract available.

PMID:
19236822
3.

[JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].

Olsson AG.

Lakartidningen. 2009 May 20-Jun 2;106(21-22):1471-5. Review. Swedish. No abstract available.

PMID:
19579435
5.

The JUPITER trial: How will it change clinical practice?

Watson KE.

Rev Cardiovasc Med. 2009 Spring;10(2):91-6. Review.

PMID:
19593321
6.

Should we measure C-reactive protein on earth or just on JUPITER?

Bajpai A, Goyal A, Sperling L.

Clin Cardiol. 2010 Apr;33(4):190-8. doi: 10.1002/clc.20681. Review.

7.

The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).

O'Keefe JH, Carter MD, Lavie CJ, Bell DS.

Postgrad Med. 2009 May;121(3):113-8. doi: 10.3810/pgm.2009.05.2010. Review.

PMID:
19491548
8.

The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.

Kones R.

Ther Adv Cardiovasc Dis. 2009 Aug;3(4):309-15. doi: 10.1177/1753944709337056. Epub 2009 May 21. Review.

PMID:
19460829
9.

Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.

de Lorgeril M, Salen P, Abramson J, Dodin S, Hamazaki T, Kostucki W, Okuyama H, Pavy B, Rabaeus M.

Arch Intern Med. 2010 Jun 28;170(12):1032-6. doi: 10.1001/archinternmed.2010.184. Review.

PMID:
20585068
10.

[The JUPITER trial: a new approach in primary prevention].

Güleç S.

Turk Kardiyol Dern Ars. 2009 Apr;37 Suppl 4:18-26. Review. Turkish.

11.

The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences.

Narla V, Blaha MJ, Blumenthal RS, Michos ED.

Vasc Health Risk Manag. 2009;5:1033-42. Epub 2009 Dec 29. Review.

12.

Lipid lowering for primary prevention.

Yusuf S, Lonn E, Bosch J.

Lancet. 2009 Apr 4;373(9670):1152-5. doi: 10.1016/S0140-6736(09)60357-3. Review. No abstract available. Erratum in: Lancet. 2009 Jul 4-2009 Jul 10;374(9683):28.

PMID:
19345816
13.

Moving toward new statin guidelines in a post-JUPITER world: principles to consider.

Ridker PM.

Curr Atheroscler Rep. 2009 Jul;11(4):249-56. Review.

PMID:
19500487
14.

Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises?

Efthimiadis A.

Angiology. 2008 Apr-May;59(2 Suppl):62S-4S. doi: 10.1177/0003319708321668. Epub 2008 Jul 15. Review.

PMID:
18628276
15.

Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?

Rizzo M, Berneis K, Spinas GA, Rini GB, Kapur NK.

Int J Clin Pract. 2009 Mar;63(3):478-85. doi: 10.1111/j.1742-1241.2008.01979.x. Review.

PMID:
19222633
16.

Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.

Kapur NK.

Expert Rev Cardiovasc Ther. 2007 Mar;5(2):161-75. Review.

PMID:
17338662
17.

[From lipid target values to the JUPITER study. Significance of achieving lipid levels specified by the guidelines and deficiencies in practice].

Márk L, Katona A.

Orv Hetil. 2009 Nov 1;150(44):2012-8. doi: 10.1556/OH.2009.28740. Review. Hungarian.

PMID:
19861287
18.

Cardiovascular risk in uremic patients: darkness after AURORA.

Robles NR, Macias JF.

Ren Fail. 2010 Jan;32(2):269-72. doi: 10.3109/08860221003602652. Review. No abstract available.

PMID:
20199190
19.

Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.

Ferdinand KC.

Expert Opin Pharmacother. 2005 Sep;6(11):1897-910. Review.

PMID:
16144509
20.

Rosuvastatin and progression of atherosclerosis.

Nicholls SJ.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):925-33. doi: 10.1586/14779072.6.7.925. Review. Erratum in: Expert Rev Cardiovasc Ther. 2009 Jan;7(1):97.

PMID:
18666843

Supplemental Content

Support Center